Yaqrit appoints new CEO Troels Jordansen to implement late clinical development and commercial strategy

Experienced private and public listed CEOSuccessful fund raising and business development track recordNew CEO available during JPM25 in San Francisco LONDON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Yaqrit, a late-stage biotech and medtech company developing lifesaving treatments for advanced liver diseases, announced today that Troels Jordansen has joined Yaqrit as Chief Executive Officer. The company is preparing several late-stage trials of its products for the treatment of complications associated with advance ...